A benefit-risk analysis of rotavirus vaccination, France, 2015.

Conclusion: The benefit-risk ratio in France is similar to that of other European countries. PMID: 29258644 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29258644?dopt=Abstract

Source: Euro Surveill - December 1, 2017 Category: Infectious Diseases Authors: Lamrani A, Tubert-Bitter P, Hill C, Escolano S Tags: Euro Surveill Source Type: research